Diabetic Ulcer Treatment Market Share

  • Report ID: 4585
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Diabetic Ulcer Treatment Market Share

North American Market Forecast

The North America diabetic ulcers treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the increasing spending on healthcare along with the presence of key market players in the region. The Centers for Medicare & Medicaid Services has reported that US healthcare spending in 2020 totaled USD 4.1 trillion, which represents 19.7% of the nation’s gross domestic product. Additionally, the increasing adoption of wound care products, coupled with the surging awareness regarding chronic wound care, the rise in technologically advanced research and development activities, and the huge diabetic population in the North America region are expected to fuel the diabetic ulcers treatment market growth in the region during the forecast period. The increasing urbanization and change in lifestyle, which include improper eating habits and a lack of exercise, are estimated to project market growth in the region as these factors increase the risk of diabetes. The rising number of the age-old population who have diabetes and foot ulcer issues are further predicted to boost the market’s growth in the region.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4585
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of diabetic ulcers treatment is estimated at USD 9.41 billion.

The diabetic ulcers treatment market size was valued at USD 8.99 billion in 2024 and is expected to cross USD 18.66 billion by the end of 2037, expanding at more than 5.9% CAGR during the forecast period i.e., between 2025-2037. Rising Prevalence of diabetes, mouth and foot ulcer, increasing medicare spending along with growing cases of gum diseases will boost the market growth.

North America industry is anticipated to dominate largest revenue share by 2037, backed by increasing spending on healthcare along with the presence of key players in the region.

The major players in the market include Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Medtronic Plc, Hill-Rom Holdings, Inc., ConvaTec Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample